David Sachs

David Sachs

CFOatImmunityBio· In proxies 2022–2025

Pay in FY2025+26% from the year before · ImmunityBio stock -22.7% the same year

David Sachs was paid $4.2M in FY2025 (Dec), up 26%. ImmunityBio stock fell 22.7% that year.

Pay$100 in the stock at the end of FY21 → $33
Pay is from the Summary Compensation Table of each ImmunityBio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ImmunityBioPublic company · 4 yr
    • CFO2022 – Present · 4 yrStock in role +32%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?